Advisor Group Holdings, Inc. Legend Biotech Corp Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$46.28 - $75.01 $694 - $1,125	15 Added 125.0%	27 $1,000
Q4 2022 Feb 10, 2023	SELL	$38.8 - $55.46 $1,939 - $2,773	-50 Reduced 80.65%	12 $0
Q3 2022 Nov 14, 2022	SELL	$38.15 - $57.1 $32,198 - $48,192	-844 Reduced 93.16%	62 $3,000
Q2 2022 Aug 10, 2022	BUY	$33.54 - $55.0 $30,387 - $49,830	906 New	906 $50,000

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.